Learn Before
Methods for determining odds of abnormal ECG readings amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Methods for determining hazard ratio for in-hospital mortality amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Methods for determining odds of cardiac arrest amongst hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data collection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydrochloroquine, or a combination
-
Data obtained from the State Health Information Network for New York (SHIN-NY) and from hospital data requests
-
Laboratory results from New York State Department of Health
-
Abstraction from hospital electronic medical records done by a team of nurses, doctors, and epidemiologists to record outcomes, illness and treatment details
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Data collection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydrochloroquine, or a combination
Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data collection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydrochloroquine, or a combination
Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data collection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydrochloroquine, or a combination
Sample selection for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination
Data/variables of interest for evaluating outcomes in hospitalized COVID-19 patients in New York City given Azithromycin, Hydroxychloroquine, or a combination